STI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL Amyloidosis

Clinical trial NCT05519527 · WITHDRAWN

Trial details

NCT number: NCT05519527
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory T Acute Lymphoblastic Leukemia Acute Myeloid Leukemia (AML)

Start date: 2022-08-16
Primary completion: 2023-02-15
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.